RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Assertio Holdings Stock

Assertio Holdings Stocks 2024

Assertio Holdings Stocks

71.03 M

Ticker

ASRT

ISIN

US04546C1062

WKN

A2P4ZQ

In 2024, Assertio Holdings had 71.03 M outstanding stocks, a 0% change from the 71.03 M stocks in the previous year.

The Assertio Holdings Stocks history

YEARNUMBER OF STOCKS (undefined USD)
2026e71.03
2025e71.03
2024e71.03
202371.03
202254.7
202143.2
202026.2
201917.7
201816.1
201715.7
201615.3
201515
201416.6
201314.4
201214
201114
201013.4
200912.9
200812.2
200711.6
200610.4
200510
20048.7

Assertio Holdings shares outstanding

The number of shares was Assertio Holdings in 2023 — This indicates how many shares 71.031 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Assertio Holdings earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Assertio Holdings's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Assertio Holdings’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Assertio Holdings's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Assertio Holdings Aktienanalyse

What does Assertio Holdings do?

Assertio Holdings Inc is a pharmaceutical company based in the USA that specializes in the development and marketing of prescription drugs in various therapeutic areas. The company's history dates back to its founding in 1995 under the name "DepoMed Inc". Since then, the company has undergone numerous changes and restructurings before eventually being renamed Assertio Holdings Inc. The business model of Assertio Holdings Inc focuses on the development and marketing of prescription drugs in areas such as pain management, neurological disorders, complex regional pain syndrome (CRPS), and migraines. An important aspect of Assertio Holdings Inc's business model is its commitment to improving the quality of life for patients affected by these conditions. The company operates several divisions specializing in different therapeutic areas. The three main divisions are: 1. Pain Management: This division focuses on the development and marketing of prescription drugs for pain relief, including opioid-containing medications. Some of the well-known products in this division include the pain medication Gralise and the Fentanyl transdermal patch. 2. Neurology: This division specializes in the development and marketing of prescription drugs for the treatment of neurological disorders such as Parkinson's disease and restless legs syndrome. Some of the well-known products in this division include the Parkinson's medication Rytary and the restless legs syndrome medication Neupro. 3. Hospital: This division focuses on the development and marketing of drugs for the treatment of diseases that typically require hospitalization, such as infections and postoperative pain. Some of the well-known products in this division include the antibiotic Zipsor and the postoperative pain medication Nucynta ER. In addition to these three main divisions, Assertio Holdings Inc also operates a smaller division called "Other." This division includes products that do not fit into the other divisions, such as the migraine medication Cambia. Overall, Assertio Holdings Inc offers a wide range of prescription drugs aimed at improving the quality of life for patients suffering from various conditions. However, in recent years, the company has had to overcome various economic challenges. In 2016, the company was accused of making false claims through the marketing of an opioid called Nucynta. As part of a settlement with the government, the company agreed to pay $35 million and commit to reforms in the marketing of Nucynta. Assertio Holdings Inc also faces a shrinking market for painkillers as the US government and public opinion grow increasingly concerned about the opioid epidemic. In response, the company has realigned its pain management division and increased its investments in novel, opioid-free pain medications. Despite these challenges, Assertio Holdings Inc continues to work on the development and marketing of prescription drugs that can play an important role in improving the health and well-being of patients. Assertio Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Assertio Holdings's Shares Outstanding

Assertio Holdings's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Assertio Holdings’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Assertio Holdings’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Assertio Holdings’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Assertio Holdings stock

How many stocks are there of Assertio Holdings?

The current number of stocks of Assertio Holdings is 71.03 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Assertio Holdings are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Assertio Holdings evolved in recent years?

The number of shares of Assertio Holdings has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Assertio Holdings as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Assertio Holdings?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Assertio Holdings pay?

Over the past 12 months, Assertio Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Assertio Holdings is expected to pay a dividend of 0 USD.

What is the dividend yield of Assertio Holdings?

The current dividend yield of Assertio Holdings is .

When does Assertio Holdings pay dividends?

Assertio Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Assertio Holdings?

Assertio Holdings paid dividends every year for the past 0 years.

What is the dividend of Assertio Holdings?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Assertio Holdings located?

Assertio Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Assertio Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Assertio Holdings from 11/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/1/2024.

When did Assertio Holdings pay the last dividend?

The last dividend was paid out on 11/1/2024.

What was the dividend of Assertio Holdings in the year 2023?

In the year 2023, Assertio Holdings distributed 0 USD as dividends.

In which currency does Assertio Holdings pay out the dividend?

The dividends of Assertio Holdings are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Assertio Holdings

Our stock analysis for Assertio Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Assertio Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.